Membrane initiated signaling by 1,25α-dihydroxyvitamin D3 in LNCaP prostate cancer cells

Advances in Experimental Medicine and Biology

Volumn 617, Issue , 2008, Pages 573-579

  Larsson, Dennis ^a   Hagberg, Malin ^a   Malek, Nahren ^a   Kjellberg, Charlotte ^a   Senneberg, Edina ^a   Tahmasebifar, Neda ^a   Johansson, Viktoria ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CALCITRIOL; STRESS ACTIVATED PROTEIN KINASE; ANTHRA(1,9 CD)PYRAZOL 6(2H) ONE; ANTHRA(1,9-CD)PYRAZOL-6(2H)-ONE; ANTHRACENE DERIVATIVE; DIHYDROXY VITAMIN D3; DIHYDROXY-VITAMIN D3; DRUG DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; VITAMIN D;

CELL INVASION; CELL MEMBRANE; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; SIGNAL TRANSDUCTION; ARTICLE; CANCER INVASION; CELL CULTURE; CELL PROLIFERATION; DRUG ANTAGONISM; DRUG COMBINATION; DRUG EFFECT; MALE; METABOLISM; NEOPLASM; PATHOLOGY; PROSTATE TUMOR;

ANTHRACENES; CELL PROLIFERATION; DRUG THERAPY, COMBINATION; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM INVASIVENESS; NEOPLASMS, HORMONE-DEPENDENT; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; VITAMIN D;

EID: 46749094667     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-69080-3_59     Document Type: Conference Paper

References (21)

1. Holick MF (2006) Vitamin D: its role in cancer prevention and treatment. Prog Bioph Mol Biol 92:49-59.
2. Haussler MR, Whitfield GK, Haussler CA, et al. (1998) The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 13:325-349.
3. Norman AW, Mizwicki MT, Norman DP (2004) Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat Rev Drug Discov 3:27-41.
4. Boyan BD, Bonewald LF, Sylvia VL, et al. (2002) Evidence for distinct membrane receptors for 1 alpha,25-(OH)2D3 and 24R,25-(OH)2D3 in osteoblasts. Steroids 67:235-246.
5. Nemere I, Farach-Carson MC, Rohe B, et al. (2004) Ribozyme knockdown functionally links a 1,25(OH)2D3 membrane binding protein (1,25D3-MARRS) and phosphate uptake in intestinal cells. PNAS 101(19):7392-7397.
6. Larsson D, Anderson D, Smith NM, et al. (2006) 24,25-dihydroxyvitamin D3 binds to catalase. J Cell Biochem 97(6):1259-1266.
7. Nemere I, Yazzie-Atkinson D, Johns DO, et al. (2002) Biochemical characterization and purification of a binding protein for 24,25- dihydroxyvitamin D3 from chick intestine. J Endocrinol 172:211-219.
8. Larsson D, Nemere I (2001) 24,25-Dihydroxyvitamin D3 and intestinal calcium transport: from receptors to physiological response. Recent Res Dev Endocrinol 2:183-198.
9. Chen TC, Holick MF (2003) Vitamin D and prostate cancer prevention and treatment. Trends Endocrinol Metab 14(9):423-430.
10. Trapman J, Brinkman AO (1996) The androgen receptor in prostate cancer. Path Res Pract 192:752-760.
11. Chen TC, Schwartz GG, Burnstein KL, et al. (2000) The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer. Clin Cancer Res 6:901-908.
12. Migliaccio A, Castoria G, Di Domenico M, et al. (2000) Steroid-induced androgen receptoroestradiol receptor beta-Src complex triggers prostate cancer cell proliferation. EMBO J 19(20):5406-5417.
13. Peterziel H, Mink S, Schonert A, et al. (1999) Rapid signalling by androgen receptor in prostate cancer cells. Oncogene 18:6322-6329.
14. Schaeffer HJ, Weber MJ (1999) Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol Cell Biol 19:2435-2444.
15. Pearson G, Robinson F, Beers Gibson T, et al. (2001) Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22:153-183.
16. Ballare C, Uhrig M, Bechtold T, et al. (2003) Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src/ Erk pathway in mammalian cells. Mol Cell Biol 23:1994-2008.
17. Bhatia M, Kirkland JB, Meckling-Gill KA (1995) Monocytic differentiation of acute promyelocytic leukemia cells in response to 1,25-dihydroxyvitamin D3 is independent of nuclear receptor binding. J Biol Chem 270:15962-15965.
18. Song X, Bishop JE, Okamura WH, et al. (1998) Stimulation of phosphorylation of mitogenactivated protein kinase by 1alpha,25-dihydroxyvitamin D3 in promyelocytic NB4 leukemia cells: a structure-function study. Endocrinology 139:457-465.
19. Schwartz Z, Ehland H, Sylvia VL, et al. (2002) 1alpha,25-dihydroxyvitamin D3 and 24R,25- dihydroxyvitamin D3 modulate growth plate chondrocyte physiology via protein kinase Cdependent phosphorylation of extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase. Endocrinology 143:2775-2786.
20. Bonaccorsi L, Marchiani S, Ferruzzi P, et al. (2006) Non-genomic effects of the androgen receptor and Vitamin D agonist are involved in suppressing invasive phenotype of prostate cancer cells. Steroids 71:304-309.
21. Marchiano S, Bonaccorsi L, Ferruzzi P, et al. (2006) The vitamin D analogue BXL-628 inhibits growth factor-stimulated proliferation and invasion of DU145 prostate cancer cells. J Cancer Res Clin Oncol 132:408.